Articles | Volume 9, issue 3
https://doi.org/10.5194/jbji-9-149-2024
https://doi.org/10.5194/jbji-9-149-2024
Original full-length article
 | 
04 Jun 2024
Original full-length article |  | 04 Jun 2024

Dosing and treatment duration of suppressive antimicrobial therapy in orthopedic implant infections: a cohort study

Jaap L. J. Hanssen, Robert J. P. van der Wal, Henrica M. J. van der Linden, Joffrey van Prehn, Henk Scheper, and Mark G. J. de Boer

Viewed

Total article views: 827 (including HTML, PDF, and XML)
HTML PDF XML Total Supplement BibTeX EndNote
688 118 21 827 19 5 6
  • HTML: 688
  • PDF: 118
  • XML: 21
  • Total: 827
  • Supplement: 19
  • BibTeX: 5
  • EndNote: 6
Views and downloads (calculated since 04 Jun 2024)
Cumulative views and downloads (calculated since 04 Jun 2024)

Viewed (geographical distribution)

Total article views: 778 (including HTML, PDF, and XML) Thereof 778 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 01 Jul 2024
Download
Short summary
Some patients with an infection of their orthopedic implant use lifelong daily antibiotics. Our research, however, suggests that it might be safe to stop after 2 to 3 years. Furthermore, we found that it is probably safe to use a lower dosage of antibiotics than normally used for these infections. We performed this study by retrospectively analyzing electronic patient files from all patients we treated in our hospital with suppressive antibiotics.